Cargando…

How acceptable is adolescent self-consent for the HPV vaccination: Findings from a qualitative study in south-west England

BACKGROUND: Human Papillomavirus (HPV) vaccination programmes have the potential to reduce the incidence of cervical cancer. The preferred age for HPV vaccination is 12–13 years for optimal benefit. The legal framework in England allows adolescents to be vaccinated without parental consent if they a...

Descripción completa

Detalles Bibliográficos
Autores principales: Audrey, Suzanne, Farr, Michelle, Roderick, Marion, Evans, Karen, Fisher, Harriet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604563/
https://www.ncbi.nlm.nih.gov/pubmed/33041101
http://dx.doi.org/10.1016/j.vaccine.2020.09.074
_version_ 1783604165052727296
author Audrey, Suzanne
Farr, Michelle
Roderick, Marion
Evans, Karen
Fisher, Harriet
author_facet Audrey, Suzanne
Farr, Michelle
Roderick, Marion
Evans, Karen
Fisher, Harriet
author_sort Audrey, Suzanne
collection PubMed
description BACKGROUND: Human Papillomavirus (HPV) vaccination programmes have the potential to reduce the incidence of cervical cancer. The preferred age for HPV vaccination is 12–13 years for optimal benefit. The legal framework in England allows adolescents to be vaccinated without parental consent if they are assessed as competent. A ‘South West Template Pathway on Self Consent for School Aged Immunisations’ was developed to improve uptake of immunisations in south-west England. STUDY AIM: To examine how acceptable the new procedures are to the young women, parents and carers, school staff and immunisation nurses involved. METHODS: The research was undertaken in two local authorities in south-west England during the 2017/18 and 2018/19 programme years. Semi-structured digitally recorded interviews were undertaken with 53 participants: one health service manager, three immunisation nurses, five staff at alternative education providers, three staff at mainstream schools, 19 young women and 22 parents. All recordings were transcribed verbatim and thematic analysis was undertaken, assisted by NVivo software. RESULTS: Most participants were not fully aware of the legal framework that enables a young person to self-consent to vaccination. There was a strong presumption that parents should make decisions affecting the health of their children. The preferred age at which the HPV vaccination is administered (12–13 years) contributed to reluctance in endorsing self-consent which was thought to have the potential to break down trust between parents and school staff, and within families. In practice, formal self-consent was rare. CONCLUSION: Unresolved issues in relation to adolescent self-consent include public and professional perceptions of young people’s rights and abilities to take responsibility for decisions affecting their health, and concerns about the impact of self-consent on relationships both within families and between professionals and the families they serve.
format Online
Article
Text
id pubmed-7604563
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Science
record_format MEDLINE/PubMed
spelling pubmed-76045632020-11-07 How acceptable is adolescent self-consent for the HPV vaccination: Findings from a qualitative study in south-west England Audrey, Suzanne Farr, Michelle Roderick, Marion Evans, Karen Fisher, Harriet Vaccine Article BACKGROUND: Human Papillomavirus (HPV) vaccination programmes have the potential to reduce the incidence of cervical cancer. The preferred age for HPV vaccination is 12–13 years for optimal benefit. The legal framework in England allows adolescents to be vaccinated without parental consent if they are assessed as competent. A ‘South West Template Pathway on Self Consent for School Aged Immunisations’ was developed to improve uptake of immunisations in south-west England. STUDY AIM: To examine how acceptable the new procedures are to the young women, parents and carers, school staff and immunisation nurses involved. METHODS: The research was undertaken in two local authorities in south-west England during the 2017/18 and 2018/19 programme years. Semi-structured digitally recorded interviews were undertaken with 53 participants: one health service manager, three immunisation nurses, five staff at alternative education providers, three staff at mainstream schools, 19 young women and 22 parents. All recordings were transcribed verbatim and thematic analysis was undertaken, assisted by NVivo software. RESULTS: Most participants were not fully aware of the legal framework that enables a young person to self-consent to vaccination. There was a strong presumption that parents should make decisions affecting the health of their children. The preferred age at which the HPV vaccination is administered (12–13 years) contributed to reluctance in endorsing self-consent which was thought to have the potential to break down trust between parents and school staff, and within families. In practice, formal self-consent was rare. CONCLUSION: Unresolved issues in relation to adolescent self-consent include public and professional perceptions of young people’s rights and abilities to take responsibility for decisions affecting their health, and concerns about the impact of self-consent on relationships both within families and between professionals and the families they serve. Elsevier Science 2020-11-03 /pmc/articles/PMC7604563/ /pubmed/33041101 http://dx.doi.org/10.1016/j.vaccine.2020.09.074 Text en © 2020 The Authors. Published by Elsevier Ltd. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Audrey, Suzanne
Farr, Michelle
Roderick, Marion
Evans, Karen
Fisher, Harriet
How acceptable is adolescent self-consent for the HPV vaccination: Findings from a qualitative study in south-west England
title How acceptable is adolescent self-consent for the HPV vaccination: Findings from a qualitative study in south-west England
title_full How acceptable is adolescent self-consent for the HPV vaccination: Findings from a qualitative study in south-west England
title_fullStr How acceptable is adolescent self-consent for the HPV vaccination: Findings from a qualitative study in south-west England
title_full_unstemmed How acceptable is adolescent self-consent for the HPV vaccination: Findings from a qualitative study in south-west England
title_short How acceptable is adolescent self-consent for the HPV vaccination: Findings from a qualitative study in south-west England
title_sort how acceptable is adolescent self-consent for the hpv vaccination: findings from a qualitative study in south-west england
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604563/
https://www.ncbi.nlm.nih.gov/pubmed/33041101
http://dx.doi.org/10.1016/j.vaccine.2020.09.074
work_keys_str_mv AT audreysuzanne howacceptableisadolescentselfconsentforthehpvvaccinationfindingsfromaqualitativestudyinsouthwestengland
AT farrmichelle howacceptableisadolescentselfconsentforthehpvvaccinationfindingsfromaqualitativestudyinsouthwestengland
AT roderickmarion howacceptableisadolescentselfconsentforthehpvvaccinationfindingsfromaqualitativestudyinsouthwestengland
AT evanskaren howacceptableisadolescentselfconsentforthehpvvaccinationfindingsfromaqualitativestudyinsouthwestengland
AT fisherharriet howacceptableisadolescentselfconsentforthehpvvaccinationfindingsfromaqualitativestudyinsouthwestengland